Literature DB >> 12914741

Skeletal requirements for optimal growth hormone replacement in the transitional years.

Annice Mukherjee1, Andrea F Attanasio, Stephen M Shalet.   

Abstract

In addition to its well-established effects on linear growth in childhood and adolescence, growth hormone (GH) has both direct and indirect actions on bone remodelling and homeostasis. In this review, the discussion begins with the influence of childhood-onset growth hormone deficiency (CO-GHD) on bone mineral accretion. The limitations of methods of assessing bone mineral density (BMD) are highlighted and specific influential factors, which affect peak bone mass achievement and therefore skeletal health in later life, are evaluated.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12914741     DOI: 10.1016/s1096-6374(03)00069-8

Source DB:  PubMed          Journal:  Growth Horm IGF Res        ISSN: 1096-6374            Impact factor:   2.372


  2 in total

Review 1.  Growth hormone treatment in adults with growth hormone deficiency: the transition.

Authors:  M E Molitch
Journal:  J Endocrinol Invest       Date:  2011-01-26       Impact factor: 4.256

2.  Pattern of Use of Biosimilar and Originator Somatropin in Italy: A Population-Based Multiple Databases Study During the Years 2009-2014.

Authors:  Ilaria Marcianò; Ylenia Ingrasciotta; Francesco Giorgianni; Valentina Ientile; Alessandro Chinellato; Daniele Ugo Tari; Rosa Gini; Salvatore Cannavò; Maurizio Pastorello; Salvatore Scondotto; Pasquale Cananzi; Giuseppe Traversa; Francesco Trotta; Valeria Belleudi; Antonio Addis; Gianluca Trifirò
Journal:  Front Endocrinol (Lausanne)       Date:  2018-03-13       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.